Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects
Tài liệu tham khảo
Slaughter, 1953, Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin, Cancer, 6, 963, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q
Figueras Nart, 2018, Defining the actinic keratosis field: a literature review and discussion, J Eur Acad Dermatol Venereol, 32, 544, 10.1111/jdv.14652
Torezan, 2013, Cutaneous field cancerization: clinical, histopathological and therapeutic aspects, An Bras Dermatol, 88, 775, 10.1590/abd1806-4841.20132300
Ianhez, 2013, The reliability of counting actinic keratosis, Arch Dermatol Res, 305, 841, 10.1007/s00403-013-1413-y
Gracia Cazaña, 2017, Comparative study of the clinical, histological, and biological characteristics of squamous cell carcinomas in areas previously treated with photodynamic therapy, Eur J Dermatol, 27, 627, 10.1684/ejd.2017.3131
Dornelas, 2009, Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis, An Bras Dermatol, 84, 469, 10.1590/S0365-05962009000500004
Hollstein, 1991, p53 mutations in human cancers, Science, 253, 49, 10.1126/science.1905840
Chung, 1993, Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract, Cancer Res, 53, 1676
Nelson, 1994, Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers, Cancer Lett, 85, 23, 10.1016/0304-3835(94)90234-8
Stratigos, 2005, Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation, J Eur Acad Dermatol Venereol, 19, 180, 10.1111/j.1468-3083.2005.01094.x
Brown, 1990, Monoclonal antibody Ki-67: its use in histopathology, Histopathology, 17, 489, 10.1111/j.1365-2559.1990.tb00788.x
Batinac, 2004, p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases, Tumori, 90, 120, 10.1177/030089160409000124
Väisänen, 2011, A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53, Hum Pathol, 42, 1103, 10.1016/j.humpath.2010.11.013
Marinescu, 2016, P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions, Rom J Morphol Embryol, 57, 691
Talghini, 2009, Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease, Pak J Biol Sci, 12, 929, 10.3923/pjbs.2009.929.933
Marconi, 2007, Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis, Stem Cells, 25, 149, 10.1634/stemcells.2006-0165
Colnaghi, 2006, Separating the anti-apoptotic and mitotic roles of survivin, J Biol Chem, 281, 33450, 10.1074/jbc.C600164200
Dohi, 2004, Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis, J Clin Invest, 114, 1117, 10.1172/JCI200422222
Breyer, 2016, Epithelial–mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma, World J Urol, 34, 709, 10.1007/s00345-015-1690-5
Xie, 2015, Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis, PLOS ONE, 10, e0116517, 10.1371/journal.pone.0116517
Jin, 2014, The expression of survivin and NF-κB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma, Tumour Biol, 35, 9905, 10.1007/s13277-014-2279-0
Malhotra, 2013, Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium, PLOS ONE, 8, e78343, 10.1371/journal.pone.0078343
Dallaglio, 2014, Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion, Br J Cancer, 110, 199, 10.1038/bjc.2013.697
Metze, 2013, Fractal dimension of chromatin: potential molecular diagnostic applications for cancer prognosis, Expert Rev Mol Diagn, 13, 719, 10.1586/14737159.2013.828889
Adam, 2006, The fractal dimension of the nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia, Cell Oncol, 28, 55
Bedin, 2010, Research article fractal dimension of chromatin is an independent prognostic factor for survival in melanoma, BMC Cancer, 10, 260, 10.1186/1471-2407-10-260
Brianezi, 2015, Changes in nuclear morphology and chromatin texture of basal keratinocytes in melasma, J Eur Acad Dermatol Venereol, 29, 809, 10.1111/jdv.12453
Mendaçolli, 2015, Nuclear morphometry and chromatin textural characteristics of basal cell carcinoma, An Bras Dermatol, 90, 874, 10.1590/abd1806-4841.20154076
Anwar, 2004, The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes, Clin Dermatol, 22, 189, 10.1016/j.clindermatol.2003.12.006
Miot, 2017, Assessing normality of data in clinical and experimental trials, J Vasc Bras, 16, 88, 10.1590/1677-5449.041117
Miot, 2018, Correlation analysis in clinical and experimental studies, J Vasc Bras, 17, 275, 10.1590/1677-5449.174118
Sourial, 2010, Correspondence analysis is a useful tool to uncover the relationships among categorical variables, J Clin Epidemiol, 63, 638, 10.1016/j.jclinepi.2009.08.008
Schmitt, 2012, Actinic keratosis: a clinical and epidemiological revision, An Bras Dermatol, 87, 425, 10.1590/S0365-05962012000300012
Ianhez, 2014, Liquid nitrogen for the treatment of actinic keratosis: a longitudinal assessment, Cryobiology, 69, 140, 10.1016/j.cryobiol.2014.06.006
Esmann, 2013, Assessing the influence of actinic keratosis on patients’ quality of life: the AKQoL questionnaire, Br J Dermatol, 168, 277, 10.1111/bjd.12036
Dréno, 2017, A novel actinic keratosis field assessment scale for grading actinic keratosis disease severity, Acta Derm Venereol, 97, 1108, 10.2340/00015555-2710
Miola, 2018, Effectiveness and safety of 0.5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial, Br J Dermatol, 179, 1081, 10.1111/bjd.16824
